Metis Global Partners LLC Sells 1,044 Shares of Stryker Co. (NYSE:SYK)

Metis Global Partners LLC lowered its position in shares of Stryker Co. (NYSE:SYK) by 6.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,603 shares of the medical technology company’s stock after selling 1,044 shares during the period. Metis Global Partners LLC’s holdings in Stryker were worth $4,373,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Bremer Bank National Association lifted its position in shares of Stryker by 4.0% during the fourth quarter. Bremer Bank National Association now owns 888 shares of the medical technology company’s stock worth $266,000 after acquiring an additional 34 shares in the last quarter. Simon Quick Advisors LLC boosted its position in Stryker by 3.0% during the 4th quarter. Simon Quick Advisors LLC now owns 1,158 shares of the medical technology company’s stock valued at $347,000 after acquiring an additional 34 shares in the last quarter. Consolidated Portfolio Review Corp lifted its holdings in shares of Stryker by 3.6% during the fourth quarter. Consolidated Portfolio Review Corp now owns 983 shares of the medical technology company’s stock valued at $294,000 after purchasing an additional 34 shares during the last quarter. FourThought Financial Partners LLC raised its holdings in Stryker by 3.3% in the 4th quarter. FourThought Financial Partners LLC now owns 1,076 shares of the medical technology company’s stock worth $322,000 after acquiring an additional 34 shares during the last quarter. Finally, MBL Wealth LLC grew its position in Stryker by 4.6% in the 4th quarter. MBL Wealth LLC now owns 850 shares of the medical technology company’s stock worth $255,000 after purchasing an additional 37 shares during the period. Institutional investors own 77.09% of the company’s stock.

Insider Transactions at Stryker

In other Stryker news, CAO William E. Berry, Jr. sold 7,690 shares of the company’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $358.48, for a total value of $2,756,711.20. Following the completion of the sale, the chief accounting officer now directly owns 3,675 shares of the company’s stock, valued at approximately $1,317,414. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 5.50% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on the stock. Robert W. Baird boosted their price target on shares of Stryker from $367.00 to $378.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 1st. Truist Financial raised their price target on shares of Stryker from $330.00 to $345.00 and gave the company a “hold” rating in a research report on Wednesday, January 31st. UBS Group boosted their price target on shares of Stryker from $339.00 to $351.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 1st. Canaccord Genuity Group raised shares of Stryker from a “hold” rating to a “buy” rating and boosted their price target for the company from $315.00 to $360.00 in a research note on Wednesday, January 31st. Finally, Evercore ISI increased their target price on shares of Stryker from $340.00 to $370.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $365.94.

Stryker Stock Down 0.9 %

Shares of NYSE:SYK traded down $2.95 during midday trading on Monday, reaching $325.50. The company had a trading volume of 1,717,386 shares, compared to its average volume of 1,332,698. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. The stock’s fifty day moving average price is $346.99 and its 200-day moving average price is $317.97. The stock has a market capitalization of $124.00 billion, a P/E ratio of 37.49, a PEG ratio of 2.56 and a beta of 0.91. Stryker Co. has a one year low of $249.98 and a one year high of $361.41.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.36 by $0.14. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The firm had revenue of $5.24 billion during the quarter, compared to analyst estimates of $5.10 billion. During the same quarter in the previous year, the firm earned $2.14 earnings per share. The firm’s revenue for the quarter was up 9.7% compared to the same quarter last year. Equities research analysts expect that Stryker Co. will post 11.94 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, April 30th. Shareholders of record on Friday, March 29th were paid a dividend of $0.80 per share. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $3.20 annualized dividend and a yield of 0.98%. Stryker’s payout ratio is 36.53%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.